NAMS
NewAmsterdam Pharma Company N.V. · Healthcare
Chief Accounting Officer Louise Frederika Kooij sold $1.2M of NewAmsterdam Pharma Company N.V.
Sold$1,208,159
$30.20Price
40,000Shares
−62%Stake
What NAMS did after the filing
- The stock from Thu, Jun 25 open, $32.78
- −14.7%
- S&P 500, same days
- +4.6%
Measured over 30 trading days, to the Aug 7 close.
Traded Mon, Jun 22. Filed Wed, Jun 24, 4:10 PM ET, after the close. Returns use the Jun 25 open and the Aug 7 close. Not investment advice.